Overview

A Study to Assess the Safety and Interaction Between Casopitant and Ketoconazole When Taken By Healthy Adults

Status:
Completed
Trial end date:
2007-08-27
Target enrollment:
Participant gender:
Summary
Casopitant may affect liver enzymes that metabolize ketoconazole. This study is designed to test the safety and the extent of the Casopitant affect on ketoconazole levels in healthy human subjects.
Phase:
Phase 1
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Casopitant
Ketoconazole